Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.990 +0.060 (+3.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
35 36 Next >
News headline image
Why Ocugen Stock Rose, Then Slipped Today ↗
An analyst launched coverage of the stock with an extremely bullish note, however... 
Via The Motley Fool
News headline image
Ocugen Likely Can’t Get a Boost From the FDA Until 2023 ↗
It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock. 
Via InvestorPlace
News headline image
54 Biggest Movers From Yesterday ↗
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon... 
Via Benzinga
News headline image
Why Shares of Ocugen Climbed Today ↗
The delta variant is lifting the tide of companies associated with COVID testing and prevention. 
Via The Motley Fool
Topics Death
News headline image
Ocugen Stock Is Well Past Its Expiration Date and It Shows ↗
There won’t be a market for COVAXIN in the US as vaccination rates continue moving up. OCGN stock doesn’t even warrant the price of a dollar. 
Via InvestorPlace
News headline image
Why Ocugen Shares Are Rallying Today ↗
Ocugen, Inc. (NASDAQ: OCGN) shares were advancing strongly Thursday after the biopharma issued a regulatory update. Pennsylvania-based Ocugen said it has initiated a rolling... 
Via Benzinga
News headline image
OCGN INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
Why Ocugen Stock Skyrocketed 339% in the First Half of 2021 ↗
The big jump resulted from the company's partnership with Bharat Biotech to commercialize COVID-19 vaccine Covaxin. 
Via The Motley Fool
News headline image
Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering ↗
While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate. 
Via InvestorPlace
News headline image
Why Shares of Ocugen Are Dropping Today ↗
Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved. 
Via The Motley Fool
News headline image
The Outlook for Ocugen Stock Has Deteriorated Further ↗
Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short. 
Via InvestorPlace
News headline image
What's Next For Ocugen Stock As It Nears Key Resistance Level? ↗
Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported... 
Via Benzinga
News headline image
42 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline... 
Via Benzinga
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory ↗
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward. 
Via InvestorPlace
News headline image
OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today ↗
OCGN stock is racing higher this morning following better-than-expected results from Ocugen's vaccine partner. Here is what you need to know. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella... 
Via Benzinga
News headline image
Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79% ↗
Armed with new data from its development partner Bharat Biotech, Ocugen Inc (NASDAQ: OCGN) plans to press ahead with plans to file for approval of their COVID-19... 
Via Benzinga
News headline image
28 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE... 
Via Benzinga
News headline image
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning! ↗
Growing trends involving OCGN stock suggest that the bears may have the upper hand this time. 
Via InvestorPlace
News headline image
Ocugen Has Had a Good Run, but the Math Says It’s Over ↗
Ocugen was a penny stock is up 180% for the year. But all good things must come to an end. And it’s time to let go of OCGN stock. 
Via InvestorPlace
News headline image
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
3 Tips for Coronavirus Investing Right Now ↗
Whether you're a cautious or aggressive investor, there's something for you in this space. 
Via The Motley Fool
Topics Cannabis
News headline image
One Bright Spot for Ocugen Investors ↗
It may equal some coronavirus vaccine revenue ahead. 
Via The Motley Fool
Topics Cannabis
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Odonate Therapeutics (NASDAQ:ODT)... 
Via Benzinga
News headline image
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Opportunity for Investors With Substantial Losses to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
How Risky Is Ocugen After Its Recent Setback? ↗
The U.S. vaccine market has slipped farther out of reach. 
Via The Motley Fool
Topics Cannabis
News headline image
Better Short-Squeeze Stock: Clover Health or Ocugen? ↗
Both have the necessary ingredients for explosive short-squeeze returns. 
Via The Motley Fool
News headline image
Why Ocugen Shares Are Slipping Today ↗
It could be due to the aftereffects of being included in a major stock index. 
Via The Motley Fool
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.